Patent-pending, embeddable NLAB technology enables pharma and agency marketers to build custom, verified HCP audiences using natural-language prompts

OptimizeRx Corp., a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare providers (HCPs) and patients at the most important decision points, announced the launch of its patent-pending Natural Language Audience Builder (NLAB), an AI-powered tool designed to be embedded within both demand-side platforms (DSPs) and agency media planning platforms.

NLAB combines real-world evidence with proprietary data from OptimizeRx’s best-in-class EHR network so life sciences companies and agency marketers can better create and manage custom HCP audiences within the media planning and buying platforms they already use. By connecting audience intelligence to point of care reach, NLAB helps identify the right providers and activate messages in the clinical workflows where prescribing decisions are made.

Marketing Technology News: MarTech Interview with Liat Barer, Chief Product Officer @ Odeeo

With NLAB, marketers can:

• Build and refine custom NPI lists without code or analyst support, and without relying on predefined segment matches
• View, rank, and filter matching HCP profile details, including specialty, patient volumes, prescribing behavior, and more
• Understand NPI-level reach and accessibility across media channels (programmatic, social, EHR, field force)
• Identify which HCPs are most likely to engage with, and take action based on, EHR advertising

This technology launch builds on OptimizeRx’s prior announcement opening programmatic access to its authenticated EHR inventory and expands the Company’s role as an infrastructure partner for life sciences manufacturers, agencies, and DSPs serving the healthcare ecosystem.

Marketing Technology News: What Marketers Need to Know About the European Accessibility Act

“Healthcare marketers need a faster way to build audiences that reflect the strategy behind each campaign, without relying on ‘good enough’ pre-built segments,” said Mike Rousselle, Chief AI Officer at OptimizeRx. “By embedding this capability into DSP and media planning platforms, we are giving pharma and agency teams an easier, more intuitive way to build custom HCP audiences, while helping DSPs bring stronger healthcare intelligence into the workflows their clients already use.”

“DSPs represent an important growth channel for OptimizeRx as more healthcare media investment moves through programmatic platforms,” said Stephen Silvestro, CEO of OptimizeRx. “By embedding audience intelligence alongside our EHR inventory directly into DSP workflows, we can help our partners deliver more differentiated value to pharma and agency clients while creating new recurring revenue streams for our business.”